Financial interest and its disclosure in scientific publications

JAMA

Volumn 280, Issue 3, 1998, Pages 225-226

  Krimsky, Sheldon ^a   Rothenberg, L S ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FINANCE; MEDICAL LITERATURE; MEDICAL RESEARCH; POLICY; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE; WRITING;

EID: 0032527546     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.3.225     Document Type: Article

References (18)

1. Thompson DF. Understanding financial conflicts of interest: sounding board. N Engl J Med. 1993; 329:573-576.
2. International Committee of Medical Journal Editors. Conflict of interest: writing for publication. Lancet. 1993;341:742.
3. Donaldson MS, Capron AM, eds. Patient Outcomes Research Teams: Managing Conflict of Interest. Washington, DC: National Academy Press; 1991:61-62.
4. Horton R. Conflict of interest in clinical research: opprobrium or obsession? Lancet. 1997;349:1112-1113.
5. Avoid financial "correctness" [editorial]. Nature. 1997;385:469.
6. Council on Scientific Affairs and Council on Ethical and Judicial Affairs. Conflicts of interest in medical center/industry research relationships. JAMA. 1990;263:2790-2793.
7. Culliton BJ. Biomedical research enters the marketplace. N Engl J Med. 1981;304:1195-1201.
8. US Congress, Committee on Government Operations, Subcommittee on Human Resources and Intergovernmental Relations. Are Scientific Misconduct and Conflict of Interest Hazardous to Our Health? Nineteenth Report. Washington, DC: US Government Printing Office; 1990.
9. Davidoff F. Where's the bias? Ann Intern Med. 1997;126:986-988.
10. Bernat JL, Goldstein ML, Ringel SP. Conflicts of interest in neurology. Neurology. 1998;50:327-331.
11. Wilkes MS, Kravitz RL. Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med. 1995;10:443-450.
12. Objectivity in research. 60 Federal Register 35810-35819 (1995).
13. Investigator financial disclosure policy. 60 Federal Register 35820-35823 (1995).
14. Krimsky S, Ennis J, Weissman R. Academic corporate ties in biotechnology: a quantitative study. Sci Tech Hum Values. 1991;16:275-287.
15. Blumenthal D, Campbell EG, Causino N, Louis KS. Participation of life-science faculty in research relationships with industry. N Engl J Med. 1996; 335:1734-1739.
16. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. JAMA. 1997; 277:927-934.
17. Krimsky S, Rothenberg L, Stott P, Kyle G. Financial interests of authors in scientific journals: a pilot study of 14 publications. Sci Eng Ethics. 1996; 2:395-410.
18. Stelfox HT, Grace C, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338: 101-106.